Kuriakose P, Das S, Mani A
Department of Medicine, Christian Medical College and Hospital, Ludhiana, Punjab, India.
Indian J Cancer. 1995 Sep;32(3):100-3.
This study was undertaken at the Christian Medical College and Hospital, Ludhiana, encompassing all patients of multiple myeloma presenting between January 01, 1982 and December 31, 1991. In all, 89 patients were included. The may Grunwald Giemsa stained bone marrow aspiration slides of each patient was examined under oil- immersion and a morphological grading made as mature (12 patients), immature (53) and plasmablastic (24). The estimated median survival for the mature category was 55 months, for immature 23 months and for plasmablastic two months. The estimated median survival on combining the mature of immature groups was 52 months, and on comparing this with the plasmablastic group, the difference in survival was found to be statistically significant (p < 0.05).
本研究在卢迪亚纳基督教医学院及医院开展,涵盖了1982年1月1日至1991年12月31日期间收治的所有多发性骨髓瘤患者。总共纳入了89例患者。对每位患者经May Grunwald Giemsa染色的骨髓穿刺涂片进行油镜检查,并进行形态学分级,分为成熟型(12例患者)、未成熟型(53例)和浆母细胞型(24例)。成熟型患者的估计中位生存期为55个月,未成熟型为23个月,浆母细胞型为2个月。成熟型与未成熟型组合并后的估计中位生存期为52个月,将其与浆母细胞型组进行比较,发现生存期差异具有统计学意义(p < 0.05)。